20240711_MEDS_Pemanggilan RUPS_31682789_lamp2.pdf

5.    Pemegang Saham yang tidak dapat hadir dalam Rapat dapat diwakilkan oleh pihak independen yang telah ditunjuk
      oleh Perseroan yaitu perwakilan dari PT Sinartama Gunita selaku Biro Administrasi Efek (“BAE”), dengan
      memberikan kuasa secara konvensional menggunakan format surat kuasa tertulis yang dapat diunduh pada
      situs web Perseroan (https://www.evoplusmed.com). Surat Kuasa wajib diisi dan diserahkan kepada BAE
      paling lambat 1 (satu) hari kerja sebelum tanggal penyelenggaraan Rapat yang beralamat di Menara Tekno
      Lantai 7 Jl. H. Fachrudin No.19 Tanah Abang, Jakarta Pusat.
6.    Pemegang Saham atau Kuasanya yang sah, yang akan menghadiri Rapat secara fisik diminta dengan hormat untuk
      menyerahkan fotokopi Kartu Tanda Penduduk (“KTP”) kepada petugas Rapat, dan wajib membawa Konfirmasi Tertulis
      Untuk Rapat (“KTUR”) yang dapat diperoleh dari Perusahaan Efek atau Bank Kustodian dimana Pemegang Saham
      membuka rekening efeknya.
7.    Bagi Pemegang Saham yang berbentuk badan hukum seperti Perseroan Terbatas, Koperasi, Yayasan, atau Dana Pensiun
      wajib membawa fotokopi anggaran dasar yang terbaru dan lengkap, serta pengesahan atas akta pendirian dan
      persetujuan atas perubahan anggaran dasar yang terakhir dari Departemen Hukum dan Hak Asasi Manusia Republik
      Indonesia berikut susunan pengurus yang terakhir.
8.    Untuk menjamin kelancaran dan tertibnya Rapat, Pemegang Saham atau Kuasanya yang sah diminta dengan hormat
      untuk hadir ditempat Rapat 30 (tiga puluh ) menit sebelum Rapat dimulai.
9.    Bahan-bahan Rapat dan Tata tertib pelaksanaan Rapat dapat diakses melalui situs web Perseroan sejak tanggal panggilan
      ini.
10.   Perseroan menghimbau para pemegang saham Perseroan untuk terlebih dahulu membaca Tata Tertib Rapat
      termasuk panduan pelaksanaan Rapat secara elektronik bagi yang akan hadir secara elektronik yang tersedia
      di aplikasi eASY.KSEI. Dengan telah disampaikannya tata tertib tersebut, maka Pemegang Saham atau Kuasanya yang
      sah dianggap telah memahami dan akan mentaati selama pelaksanaan Rapat berlangsung.




                                                 Cimahi, 18 Juli 2024
                                          PT HETZER MEDICAL INDONESIA TBK
                                                  Direksi Perseroan

                                                      INVITATION
                                                   TO SHAREHOLDERS
                                            PT HETZER MEDICAL INDONESIA Tbk



The Board of Directors of PT Hetzer Medical Indonesia Tbk (the “Company”) hereby invites the shareholders of the
Company to attend the Extraordinary General Meeting of Shareholders (the “Meeting”), which will be held on:
    Day/Date                            : Friday, August 09, 2024
    Time                                : 10.00 am until finish
    Venue                               : Company Office
                                           Kompleks Blue Sky Industrial Kav. 09, Jl. Nanjung No. 02
                                           Kelurahan Leuwigajah, Kecamatan Cimahi Selatan, Kota Cimahi.

The agenda items that will be proposed at the Meeting to be discussed and obtain decisions from the Company's
shareholders are as follows:

1.    Approval of the Feasibility Study Report prepared by the Independent Appraisal Services Office for the Company's Plans
      to Add Business Activities to Fulfill the Provisions of Financial Services Authority Regulation No.17/POJK.04/2020
      concerning Material Transactions and Changes in Business Activities
      Explanation :
      Based on Article 22 paragraph (3) POJK Number 17 of 2020 concerning Material Transactions and Changes in Business
      Activities, it contains "... there must be a special agenda item regarding the discussion of feasibility studies regarding
      changes to open business activities...".
2.    Approval of changes to the Company's aims and objectives and business activities
      Explanation:
      In connection with the addition of the Company's business fields as discussed in the 1st EGMS agenda and
      based on Article 19 of Law Number 40 of 2007 About Limited Liability Company, any changes to the
      Company's articles of association need to be determined by the General Meeting of Shareholders



Notes:
1.     The meeting will be held concerning Financial Services Authority Regulation Number 15/POJK.04/2020 concerning
       Planning and Organizing General Meetings of Shareholders of Public Companies and Financial Services Authority
       Regulation Number 16/POJK.04/2020 concerning Implementation of General Meetings of Shareholders of Companies
       Open Electronically.
2.     The Company does not send a separate invitation to each shareholder of the Company, so this invitation is an official
       invitation for all Shareholders of the Company. This summons can also be seen on the Company's website
       (https://www.evoplusmed.com), the electronic GMS holding application ("eASY.KSEI") provided by PT Kustodian Sentral
       Efek Indonesia ("KSEI") which can be accessed via the KSEI website (https://akses.ksei.co.id), and the PT Bursa Efek
       Indonesia (“BEI”) website.
3.     Shareholders who have the right to attend or be represented at the Meeting are the Company's Shareholders whose
       names are registered in the Company's Register of Shareholders at the close of Stock Exchange trading hours on 17 July
       2024.
4.     Shareholder participation in the Meeting can be carried out using the following mechanism:
       a.      Be physically present at the meeting; or
       b.      Attend the Meeting electronically via the eASY.KSEI application.

5.    Shareholders who are unable to attend the Meeting can be represented by an independent party appointed by the
      Company, namely a representative from PT Sinartama Gunita as the Securities Administration Bureau ("BAE"), by
      providing conventional power of attorney using a written power of attorney format which can be downloaded at the
      Company website (https://www.evoplusmed.com). The Power of Attorney must be filled out and submitted to BAE no
      later than 1 (one) working day before the date of the Meeting which is located at Menara Tekno Floor 7 Jl. H. Fachrudin
      No.19 Tanah Abang, Central Jakarta.
6.    Shareholders or their legal proxies, who will physically attend the Meeting are kindly requested to submit a photocopy of
      their Resident Identification Card (“KTP”) to the meeting officer and are required to bring Written Confirmation for the
      Meeting (“KTUR”) which can be obtained from Securities Company or Custodian Bank where Shareholders open their
      securities accounts.
7.    Shareholders in the form of legal entities such as Limited Liability Companies, Cooperatives, Foundations, or Pension Funds
      are required to bring a photocopy of the most recent and complete articles of association, as well as ratification of the
      deed of establishment and approval of the latest amendments to the articles of association from the Department of Law
      and Human Rights. Republic of Indonesia following the latest management structure.
8.    To ensure the smooth and orderly running of the Meeting, Shareholders or their legal proxies are kindly requested to be
      present at the Meeting venue 30 (thirty) minutes before the Meeting starts.
9.    Meeting materials and Meeting Rules and Regulations can be accessed via the Company's website from the date of this
      summons.
10.   The Company urges the Company's shareholders to first read the Meeting Rules of Conduct including the guidelines for
      conducting electronic Meetings for those who will attend electronically which are available on the eASY.KSEI application.
      By submitting these rules and regulations, the Shareholders or their legal proxies are deemed to have understood and will
      comply during the Meeting.




                                                  Cimahi, July 18, 2024
                                           PT HETZER MEDICAL INDONESIA TBK
                                           Board of Directors of the Company